This study demonstrated that DHS attenuates the CS-induced pulmonary impairments through inhibition of oxidative stress and inflammatory responses targeting Nrf2 and NF-κB “in vitro” and “in vivo”, and could be developed into a preventive agent against pulmonary impairments induced by CS [152]. The gene discussed is NFKB1; the disease is Cowden syndrome 1.